Cygnus Technologies

HCP ELISA and HCP Antibody Coverage Analysis Methods

April 05, 2021

Biopharma Insights - Thought Leadership from Marketers | Paid Program

Predicting Viral Clearance at Your Benchtop

July 27, 2020

Biopharma Insights - Thought Leadership from Marketers | Paid Program

Viral contamination is an inherent risk during the manufacture of therapeutic products such as antibodies, vaccines, viral vectors, and plasma derivates.